Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | JZP898 |
Synonyms | |
Therapy Description |
JZP898 comprises IFNalpha2b linked to half-life extension domains by protease-sensitive linkers that are cleaved to in the presence of proteases in the tumor microenvironment to release IFNalpha2b, potentially inducing IFNalpha signaling and increased anti-tumor immune response (Cancer Res (2023) 83 (7_Supplement):1817). |